Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock

O'Connell, 2000, The economic burden of heart failure, Clin Cardiol, 23, III6, 10.1002/clc.4960231503 Osman, 2021, Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States, J Am Heart Assoc, 10, 10.1161/JAHA.121.021061 Shaefi, 2015, Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock, J Am Heart Assoc, 4, 10.1161/JAHA.114.001462 Pirracchio, 2013, The effectiveness of inodilators in reducing short term mortality among patients with severe cardiogenic shock: a propensity-based analysis, PLOS ONE, 8, e71659, 10.1371/journal.pone.0071659 Van Diepen, 2017, Contemporary management of cardiogenic shock: a scientific statement from the American heart association, Circulation, 136, 10.1161/CIR.0000000000000525 Marius-Nunez, 1996, Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure, Am Heart J, 132, 805, 10.1016/S0002-8703(96)90315-4 Oliva, 1999, Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial, Am Heart J, 138, 247, 10.1016/S0002-8703(99)70108-0 Yamani, 2001, Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact, Am Heart J, 142, 998, 10.1067/mhj.2001.119610 Abraham, 2005, In-Hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications, J Am Coll Cardiol, 46, 57, 10.1016/j.jacc.2005.03.051 Gorodeski, 2009, Prognosis on chronic dobutamine or milrinone infusions for stage d heart failure, Circ Heart Fail, 2, 320, 10.1161/CIRCHEARTFAILURE.108.839076 Hauptman, 2008, Resource utilization in patients hospitalized with heart failure: Insights from a contemporary national hospital database, Am Heart J, 155, 10.1016/j.ahj.2008.01.015 Kelly, 2020, Comparison of positive inotropic agents in the management of acute decompensated heart failure, J Cardiovasc Pharmacol, 75, 455, 10.1097/FJC.0000000000000811 Lewis, 2018, Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock, J Cardiovasc Pharmacol Ther, 24, 130, 10.1177/1074248418797357 Mathew, 2021, Milrinone as compared with dobutamine in the treatment of cardiogenic shock, N Engl J Med, 385, 516, 10.1056/NEJMoa2026845 Koster, 2016, Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis, Intensive Care Med, 42, 1322, 10.1007/s00134-016-4449-6 Di Santo, 2021, Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial, Crit Care Med, 25 Aranda, 2003, Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial, Am Heart J, 145, 324, 10.1067/mhj.2003.50